This Article Full Text Full Text (PDF) All Versions of this Article: 102/3/302    most recent CIRCRESAHA.107.157990v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schmidt, R. Articles by May, A. E. Search for Related Content PubMed PubMed Citation Articles by Schmidt, R. Articles by May, A. E. Related Collections Pathophysiology Cell biology/structural biology Cell signalling/signal transduction Morphology Signal transduction Platelets Mechanism of atherosclerosis/growth factors

(Circulation Research. 2008;102:302.)
© 2008 American Heart Association, Inc.

Molecular Medicine

Extracellular Matrix Metalloproteinase Inducer (CD147) Is a Novel Receptor on Platelets, Activates Platelets, and Augments Nuclear Factor B–Dependent Inflammation in Monocytes

Roland Schmidt, Andreas Bültmann, Sina Fischel, Angelika Gillitzer, Paul Cullen, Axel Walch, Philipp Jost, Martin Ungerer, Neal D. Tolley, Stephan Lindemann, Meinrad Gawaz, Albert Schömig, Andreas E. May

From the Deutsches Herzzentrum and I. Medizinische Klinik (R.S., S.F., A.S.) and III. Medizinische Klinik (P.J.), Klinikum rechts der Isar, Technische Universität München, Germany; Corimmun GmbH (A.B., A.G., M.U.), Martinsried, Germany; Medizinisches Versorgungzentrum für Laboratoriumsmedizin Dr. Löer, Dr. Treder, und Kollegen (P.C.), Muenster, Germany; Forschungszentrum für Umwelt und Gesundheit (A.W.), Oberschleissheim, Germany; Department of Internal Medicine (N.D.T.), Eccles Institute of Human Genetics, University of Utah, Salt Lake City; and Medizinische Klinik III (S.L., M.G., A.E.M.), Eberhard-Karls Universität Tübingen, Germany.

Correspondence to Roland Schmidt, MD, Deutsches Herzzentrum und I. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Lazarettstr. 36, 80636 München, Germany. E-mail schmidtr{at}dhm.mhn.de

In atherosclerosis, circulating platelets interact with endothelial cells and monocytes, leading to cell activation and enhanced recruitment of leukocytes into the vascular wall. The invasion of monocytes is accompanied by overexpression of matrix metalloproteinases (MMPs), which are thought to promote atherosclerosis and trigger plaque rupture. Following interaction with itself, the extracellular matrix metalloproteinase inducer (EMMPRIN) induces MMP synthesis via a little-known intracellular pathway. Recently, we showed upregulation of EMMPRIN on monocytes during acute myocardial infarction. EMMPRIN also stimulates secretion of MMP-9 by monocytes and of MMP-2 by smooth muscle cells, indicating that it may be an important regulator of MMP activity. Expression of EMMPRIN on platelets has not been described until now. Here, we demonstrate that resting platelets show low surface expression of EMMPRIN, which is upregulated by various platelet stimulators (flow cytometry). EMMPRIN is located in the open canalicular system and in granules of platelets (according to electron microscopy and sucrose gradient ultracentrifugation). Platelet stimulation with recombinant EMMPRIN-Fc induced surface expression of CD40L and P-selectin (according to flow cytometry), suggesting that EMMPRIN-EMMPRIN interaction activates platelets. Coincubation of platelets with monocytes induced EMMPRIN-mediated nuclear factor B activation (according to Western blot) in monocytes with increased MMP-9 (zymography), interleukin-6, and tumor necrosis factor- secretion (according to ELISA) by monocytes. In conclusion, EMMPRIN displays a new platelet receptor that is upregulated on activated platelets. Binding of EMMPRIN to platelets fosters platelet degranulation. Platelet–monocyte interactions via EMMPRIN stimulate nuclear factor B–driven inflammatory pathways in monocytes, such as MMP and cytokine induction. Thus, EMMPRIN may represent a novel target to diminish the burden of protease activity and inflammation in atherosclerosis.

Key Words: platelet receptor • inflammation • leukocytes • metalloproteinases • plaque

This article has been cited by other articles:

				E. Shantsila and G. Y.H. Lip Monocytes in Acute Coronary Syndromes Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1433 - 1438. [Abstract] [Full Text] [PDF]

				B. Venkatesan, A. J. Valente, V. S. Reddy, D. A. Siwik, and B. Chandrasekar Resveratrol blocks interleukin-18-EMMPRIN cross-regulation and smooth muscle cell migration Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H874 - H886. [Abstract] [Full Text] [PDF]

				P. T.G. Bot, I. E. Hoefer, J. P.G. Sluijter, P. van Vliet, A. M. Smits, F. Lebrin, F. Moll, J.-P. de Vries, P. Doevendans, J. J. Piek, et al. Increased Expression of the Transforming Growth Factor-{beta} Signaling Pathway, Endoglin, and Early Growth Response-1 in Stable Plaques Stroke, February 1, 2009; 40(2): 439 - 447. [Abstract] [Full Text] [PDF]